Ramsay Santé
Coline Bazalgette Roussaly is a highly skilled fiscaliste with extensive experience in corporate taxation. Currently serving as a senior corporate tax advisor at Ramsay Santé since June 2021, Coline manages the fiscal integration of 200 companies and oversees group tax obligations. Responsibilities include validating deferred taxes, participating in group restructuring operations, handling tax audits, and maintaining relationships with tax authorities. Previously, Coline held the position of corporate tax advisor at Suez from 2010 to 2020, dealing with fiscal integration for 130 companies and providing assistance during tax audits. Coline's career began as a tax lawyer at SCP De Foucher Guey Chretien, where legal and fiscal matters were addressed. Coline holds two Master 2 degrees in Public Finances and Business Law and Taxation from University of Paris I: Panthéon-Sorbonne, Université Paris Nanterre, and Université d'Orléans.
This person is not in any offices
Ramsay Santé
1 followers
After the acquisition of the Capio Group in 2018, Ramsay Santé has become Europe's leading private hospital and primary care companies. The group now has 36,000 employees and works with nearly 8,600 private practitioners. Present in 5 countries, France, Sweden, Norway, Denmark and Italy, the group treats more than 7 million patients per year in its 350 establishments. In hospitalization, Ramsay Santé offers almost all medical and surgical treatments in three business lines: Medicine-Surgery-Obstetrics (MCO), Follow-up and Rehabilitation Care (SSR) and Mental Health. Wherever it is present, the group participates in public health service missions and in the health network of the country, as in Sweden where the group has more than a hundred local health centres. The quality and safety of care is the group's priority in all the countries where it operates. This is why the group is today one of the references in modern medicine, especially in ambulatory surgery and enhanced recovery after surgery (ARS). The group also invests more than €200 million every year in its establishments, whether in new surgical and imaging technologies, or in the construction and modernisation of establishments. It also innovates at the service of patients with new digital tools and by developing its organisations to improve the efficiency of care.